Azzur Group and BioSPEQ Announce Merger - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Azzur Group and BioSPEQ Announce Merger


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 5

Azzur Group and BioSPEQ, a California-based consulting firm, have merged to create a union that will provide consulting services and project resources within the QA, laboratory, clinical, information technology, business processes, manufacturing, operations, and R&D settings.

The Azzur-BioSPEQ merger is the latest in a series of new developments for Azzur Group. Earlier this month, the company acquired Azot and formed Azzur Engineering.

Azzur Group’s main office is located in Willow Grove, PA, with additional offices in Frederick, MD, San Antonio, TX, Cambridge, MA, Cary, NC and Palo Alto, CA. BioSPEQ is headquartered in Irvine, CA with additional offices in Lexington, MA and San Diego, CA.

Source: Azzur Group

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here